Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Follow-Up of ELND005 in Alzheimer's Disease
NCT00934050Phase 2Completed
- Sponsor
- OPKO Health
- Start
- Jun 2009
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of scyllo-inositol in Alzheimer's disease (AD), sponsored by OPKO Health. Started Jun 2009; status: completed.
02
Drugs
scyllo-inositol
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00934050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00934050.